Jan Basile to Disease Progression
This is a "connection" page, showing publications Jan Basile has written about Disease Progression.
Connection Strength
0.207
-
Comparison of aliskiren/hydrochlorothiazide combination therapy with hydrochlorothiazide monotherapy in older patients with stage 2 systolic hypertension: results of the ACTION study. J Clin Hypertens (Greenwich). 2011 Mar; 13(3):162-9.
Score: 0.075
-
Clinical considerations and practical recommendations for the primary care practitioner in the management of anemia of chronic kidney disease. South Med J. 2007 Dec; 100(12):1200-7.
Score: 0.060
-
Halting the progression of heart failure: finding the optimal combination therapy. Cleve Clin J Med. 2002 Feb; 69(2):104-5, 109-10, 112.
Score: 0.040
-
Does prehypertension represent an increased risk for incident hypertension and adverse cardiovascular outcome? Hypertension. 2009 Nov; 54(5):954-5.
Score: 0.017
-
Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Am J Kidney Dis. 2008 Sep; 52(3):412-24.
Score: 0.016